EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 253 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,015,813 | -43.7% | 424,709 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $8,914,642 | -17.7% | 424,709 | +21.8% | 0.00% | -33.3% |
| Q2 2022 | $10,826,224 | -38.9% | 348,783 | -19.2% | 0.00% | -25.0% |
| Q1 2022 | $17,714,146 | -4.4% | 431,421 | +1.2% | 0.00% | 0.0% |
| Q4 2021 | $18,535,000 | -11.7% | 426,388 | +1.7% | 0.00% | -20.0% |
| Q3 2021 | $20,999,000 | +269.4% | 419,388 | +364.8% | 0.01% | +400.0% |
| Q2 2021 | $5,684,000 | -78.6% | 90,238 | -68.4% | 0.00% | -83.3% |
| Q1 2021 | $26,509,000 | -43.6% | 285,316 | -45.6% | 0.01% | -45.5% |
| Q4 2020 | $46,995,000 | -6.7% | 524,498 | +7.6% | 0.01% | -15.4% |
| Q3 2020 | $50,365,000 | +31.0% | 487,418 | +0.2% | 0.01% | +18.2% |
| Q2 2020 | $38,449,000 | +19.4% | 486,210 | -12.6% | 0.01% | 0.0% |
| Q1 2020 | $32,206,000 | +7.2% | 556,615 | 0.0% | 0.01% | +37.5% |
| Q4 2019 | $30,029,000 | +3.2% | 556,615 | 0.0% | 0.01% | -11.1% |
| Q3 2019 | $29,099,000 | +8.2% | 556,615 | 0.0% | 0.01% | +12.5% |
| Q2 2019 | $26,890,000 | -30.5% | 556,615 | -27.3% | 0.01% | -33.3% |
| Q1 2019 | $38,683,000 | -22.0% | 765,714 | -8.5% | 0.01% | -33.3% |
| Q4 2018 | $49,581,000 | -10.0% | 836,399 | 0.0% | 0.02% | 0.0% |
| Q3 2018 | $55,060,000 | +33.0% | 836,399 | +2.0% | 0.02% | +28.6% |
| Q2 2018 | $41,392,000 | +37.8% | 819,821 | +43.7% | 0.01% | +27.3% |
| Q1 2018 | $30,043,000 | +25.1% | 570,625 | +10.5% | 0.01% | +22.2% |
| Q4 2017 | $24,008,000 | +33.8% | 516,628 | +16.4% | 0.01% | +28.6% |
| Q3 2017 | $17,947,000 | +19.3% | 443,675 | 0.0% | 0.01% | +16.7% |
| Q2 2017 | $15,045,000 | +37.6% | 443,675 | +17.8% | 0.01% | +50.0% |
| Q1 2017 | $10,934,000 | -11.6% | 376,506 | 0.0% | 0.00% | -20.0% |
| Q4 2016 | $12,364,000 | +9.0% | 376,506 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $11,338,000 | +28.6% | 376,506 | +20.1% | 0.01% | +25.0% |
| Q2 2016 | $8,816,000 | +34.4% | 313,506 | +73.8% | 0.00% | +33.3% |
| Q1 2016 | $6,558,000 | – | 180,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
| Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
| AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
| PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
| RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
| EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
| SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
| Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
| DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |